Expedia, Mastercard, and Neurocrine Experience High Options Trading Volume

Among the underlying components of the Russell 3000 index, notable options trading volume emerged today for several companies. **Expedia Group Inc (Symbol: EXPE)** recorded a total of 8,586 contracts traded, reflecting approximately 858,600 underlying shares. This figure represents about 41.3% of EXPE’s average daily trading volume of 2.1 million shares over the past month. Most prominently, the $165 strike put option expiring on April 17, 2025, saw 1,004 contracts traded, amounting to around 100,400 underlying shares of EXPE.

Below is a chart depicting EXPE’s trailing twelve-month trading history, with the $165 strike highlighted in orange:

**Mastercard Inc (Symbol: MA)** also recorded significant options activity, with 10,330 contracts traded, equating to approximately 1.0 million underlying shares. This volume constitutes roughly 40.5% of MA’s average daily trading volume of 2.5 million shares over the previous month. The $545 strike call option expiring on March 14, 2025, was particularly active, with 739 contracts traded, corresponding to about 73,900 underlying shares of MA.

Here is a chart illustrating MA’s trailing twelve-month trading history, with the $545 strike highlighted in orange:

**Neurocrine Biosciences, Inc. (Symbol: NBIX)** saw an options trading volume of 6,125 contracts today, translating to approximately 612,500 underlying shares. This volume represents about 40.3% of NBIX’s average daily trading volume of 1.5 million shares over the past month. Noteworthy trading occurred with the $125 strike put option expiring on March 21, 2025, which had 3,006 contracts traded, representing around 300,600 underlying shares of NBIX.

Below is a chart displaying NBIX’s trailing twelve-month trading history, with the $125 strike highlighted in orange:

For information regarding the various expirations available for EXPE, MA, or NBIX options, visit StockOptionsChannel.com.

Today’s Most Active Call & Put Options of the S&P 500 »

Also see:

• AMBT Historical Stock Prices
• Top 10 Hedge Funds Holding MCD
• Top Ten Hedge Funds Holding PAVS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.